Novo Nordisk to acquire Cardior Pharmaceuticals for €1.025 billion Economy March 25, 2024 BAGSVÆRD, Denmark – Novo Nordisk (NYSE:), a global healthcare company, has announced its agreement to purchase Cardior Pharmaceuticals for up…